Endoscopic Activity and Baseline Serum TNF-α Level Associated With Response to Ustekinumab in Patients With Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Endoscopic Activity and Serum TNF-α Level at Baseline Are Associated With Clinical Response to Ustekinumab in Crohn's Disease Patients
Inflamm. Bowel Dis. 2020 Oct 23;26(11)1669-1681, K Murate, K Maeda, M Nakamura, D Sugiyama, H Wada, T Yamamura, T Sawada, Y Mizutani, T Ishikawa, K Furukawa, E Ohno, T Honda, H Kawashima, R Miyahara, M Ishigami, H Nishikawa, M FujishiroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.